HSTM Quote, Financials, Valuation and Earnings

Schrodinger has a net margin of 5.9% compared to HealthStream's net margin of -100.43%. HealthStream's return on equity of 5.39% beat Schrodinger's return on equity of -43.06%.

HealthStream has a consensus price target of $34.50, signalling upside risk potential of 26.61%. On the other hand Schrodinger has an analysts' consensus of $31.78 which suggests that it could grow by 48.29%. Given that Schrodinger has higher upside potential than HealthStream, analysts believe Schrodinger is more attractive than HealthStream.

HealthStream has a beta of 0.432, which suggesting that the stock is 56.846% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.633, suggesting its more volatile than the S&P 500 by 63.305%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.43%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthStream pays 17.01% of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $73.5M, which are larger than Schrodinger quarterly revenues of $59.6M. HealthStream's net income of $4.3M is higher than Schrodinger's net income of -$59.8M. Notably, HealthStream's price-to-earnings ratio is 43.25x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 2.85x versus 6.77x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus has a net margin of 5.9% compared to HealthStream's net margin of 13.7%. HealthStream's return on equity of 5.39% beat Simulations Plus's return on equity of 3.97%.

HealthStream has a consensus price target of $34.50, signalling upside risk potential of 26.61%. On the other hand Simulations Plus has an analysts' consensus of $36.25 which suggests that it could grow by 90.09%. Given that Simulations Plus has higher upside potential than HealthStream, analysts believe Simulations Plus is more attractive than HealthStream.

HealthStream has a beta of 0.432, which suggesting that the stock is 56.846% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.973, suggesting its less volatile than the S&P 500 by 2.692%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.43%. Simulations Plus offers a yield of 1.26% to investors and pays a quarterly dividend of $0.06 per share. HealthStream pays 17.01% of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $73.5M, which are larger than Simulations Plus quarterly revenues of $22.4M. HealthStream's net income of $4.3M is higher than Simulations Plus's net income of $3.1M. Notably, HealthStream's price-to-earnings ratio is 43.25x while Simulations Plus's PE ratio is 54.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 2.85x versus 4.93x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

Veeva Systems has a net margin of 5.9% compared to HealthStream's net margin of 30.06%. HealthStream's return on equity of 5.39% beat Veeva Systems's return on equity of 14.13%.

HealthStream has a consensus price target of $34.50, signalling upside risk potential of 26.61%. On the other hand Veeva Systems has an analysts' consensus of $291.65 which suggests that it could grow by 3.22%. Given that HealthStream has higher upside potential than Veeva Systems, analysts believe HealthStream is more attractive than Veeva Systems.

HealthStream has a beta of 0.432, which suggesting that the stock is 56.846% less volatile than S&P 500. In comparison Veeva Systems has a beta of 0.990, suggesting its less volatile than the S&P 500 by 1.04%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.43%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthStream pays 17.01% of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $73.5M, which are smaller than Veeva Systems quarterly revenues of $759M. HealthStream's net income of $4.3M is lower than Veeva Systems's net income of $228.2M. Notably, HealthStream's price-to-earnings ratio is 43.25x while Veeva Systems's PE ratio is 59.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 2.85x versus 16.38x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.